Trinity Biotech Announces Quarter 3 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Craig-Hallum Downgrades Trinity Biotech (TRIB) to Hold
October 23, 2015 8:06 AM EDTCraig-Hallum downgraded Trinity Biotech (NASDAQ: TRIB) from Buy to Hold with a price target of $14.00 (from $24.00).
For an analyst ratings summary and ratings history on Trinity Biotecjh click here. For more ratings news on Trinity Biotecjh click here.
Shares of Trinity Biotecjh closed at $13.02 yesterday.
... MoreTrinity Biotech Plc (TRIB) Tops Q3 EPS by 1c
October 22, 2015 8:38 AM EDTTrinity Biotech Plc (NASDAQ: TRIB) reported Q3 EPS of $0.10, $0.01 better than the analyst estimate of $0.09. Revenue for the quarter came in at $27.2 million versus the consensus estimate of $25.4 million.
For earnings history and earnings-related data on Trinity Biotech Plc (TRIB) click here.
... More


